Lung Cancer: Co-Chaired by David Spigel, MD and Melissa L. Johnson, MD

Partner | Cancer Centers | <b>Sarah Cannon</b>

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of lung cancer.

The live filming of this virtual event in our IPC series is now on-demand.

Early detection, personalized treatment approaches, and increased situational awareness have improved cancer patient survival rates. Ongoing dialogue among leading experts can only improve patient outcomes and advance the field of lung cancer.

Speakers

  • Davey B. Daniel, MD | Tennessee Oncology
  • David Spigel, MD | Sarah Cannon Research Institute at Tennessee Oncology
  • Melissa L. Johnson, MD | Sarah Cannon Research Institute at Tennessee Oncology
  • Andrew McKenzie, PhD | Sarah Cannon Research Institute

Topics

  • IO for NSCLC
  • Early Stage
  • New Targets in Advanced NSCLC
  • Molecular Profiling in NSCLC - Tumor vs. Plasma